Sanofi's quadrivalent flu shot safe in kids; No increased risk to babies for H1N1 vax in pregnancy;

> Sanofi Pasteur's quadrivalent version of its Fluzone flu vaccine was safe and effective in a Phase III trial in children aged 6 months to 8 years. Press release

> There is no evidence of increases in fetal death in pregnant women receiving a pandemic A/H1N1 influenza vaccine during pregnancy. Abstract

> Inovio's SynCon vaccine for cervical dysplasias and cancers has been granted a U.S. patent. Article

> Profectus has received an NIAID grant to develop a vaccine against Ebola and Marburg viruses. Press release

> Galena Biopharma ($GALE) has received a notice of allowance for a U.S. patent for folate binding protein vaccines. Press release

And Finally… Allergy Therapeutics, which specializes in allergy vaccines, has appointed Dr. Thomas Lander as a non-executive director. Press release

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.